Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New histone deacetylase inhibitors in early development at Syrrx

Nov. 17, 2004

Glufosfamide receives fast track status for pancreatic cancer

Nov. 17, 2004

Rigel and Merck & Co. partner on ubiquitin ligases research for cancer

Nov. 17, 2004

Preliminary data on the antitumor efficacy and safety of patupilone in NSCLC

Nov. 16, 2004

Antitumor effects reported for EKB-569 plus FOLFIRI in advanced colorectal cancer

Nov. 16, 2004

Ziopharm licenses proprietary form of isophosphoramide mustard

Nov. 16, 2004

Antitumor efficacy of PR-350 plus intraoperative radiotherapy in pancreatic cancer

Nov. 15, 2004

Novartis discloses antitumor agents

Nov. 15, 2004

Protein kinase modulators described in a Sugen patent

Nov. 15, 2004

Selenite sodium reduces radiation-associated diarrhea in uterine cancer patients

Nov. 15, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...